Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Covid-19 autumn booster jabs - who is eligible, when you can get them and how to book

Millions will be able to book an appointment to get the Covid booster jab

Manchester Evening News

When will Omicron boosters be available? Who is eligible for Covid jab and how to book

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme

Daily Mirror

Omicron boosters: Do I need one, and if so, when?

Updated COVID boosters are now available for anyone age 12 or older. The CDC is urging anyone who is eligible to sign up but some vaccine experts say some people might want to wait.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

Better COVID vaccines are on the way. What do they do? And what technology might we see in future?

Regulators in Australia and the United States last week approved Omicron-specific boosters, following approval in the United Kingdom in mid-August.

The Conversation

Application for Omicron vaccine expected in 'the coming months'

It could take several months for Pfizer's new Omicron-specific vaccines to be available in New Zealand.

Newsroom.co.nz

Second Covid booster jab approved in UK ahead of winter vaccine programme

It’s the second jab aimed at both the original and Omicron strains of the virus, to be approved in the UK

Evening Standard

New 'second generation' Pfizer Covid vaccine approved ahead of booster programme

The "bivalent" jab - which targets Omicron as well as the original strain of the deadly virus - is manufactured by Pfizer/Biotech, and follows a similar booster from Moderna approved last month

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

A new vaccine which protects against two strains of covid has been approved for the NHS to use this autumn

It targets both the original strain of coronavirus and the Omicron variant

Manchester Evening News

Pfizer/BioNTech Covid-19 booster approved by UK medicines regulator

The vaccine targets both the original strain of coronavirus and the Omicron variant.

The Independent UK

3 Stocks to Buy That Won’t Give You Any Headaches

The stock market has witnessed significant volatility amid the record high inflation and the Fed’s hawkish stance on it. Investors have been banking on healthcare stocks as they tend to hold up relatively well in such turbulent times. We think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer…

StockNews.com

New COVID boosters against Omicron: everything you need to know (UPDATED)

Government health officials said Tuesday that, unless another variant emerges, it’s likely that coronavirus boosters will become a yearly thing, much like flu shots.

Chicago Sun-Times

Pfizer, Moderna Dip Despite CDC Green-Light For Updated Covid Shots

The CDC green-lighted updated Covid booster shots from Pfizer with BioNTech and Moderna, but vaccine stocks largely dipped Friday.

Investors Business Daily

Pfizer criticised by conservatives for excluding white and Asian applicants from scholarship programme

Company says scheme will boost minority representation

The Independent UK

Dow Jones, Other Indexes Reverse Lower; Warren Buffett Sells More BYD Stock

A sudden rise in the unemployment rate tempered today's strong payroll numbers.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Does Paxlovid cause Covid rebound?

US president and first lady have both reported relapses after using drug to treat coronavirus

Benzinga

Is Cannabis Legalization The End For Pharma Stocks? New Study Predicts Billions In Losses

Federal cannabis legalization might reduce conventional pharmaceutical sales by billions of dollars according to a new study cond

The Independent UK

EXPLAINER: Should you get a new COVID booster? If so, when?

New COVID-19 boosters targeting today’s most common omicron strains should begin arriving within days

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

Get all your
news in one place.

100’s of premium titles.
One news app.

Radio France Internationale

EU regulator gives green light to omicron booster vaccines

The European Medicines Agency (EMA) has backed two separate Covid-19 booster vaccines updated to target the omicron variant of Covid-19 and developed by drugmakers Moderna and BioNTech-Pfizer.

The Denver Post

New omicron COVID-19 boosters are coming. Here’s what you need to know

DENVER — COVID-19 booster shots with a new omicron-targeting recipe are expected to arrive in pharmacies and clinics next week, but the experience of getting them will be largely the same as previous rounds of the vaccine.

Reuters

Denmark expects winter without COVID restrictions - health minister

Denmark is preparing to go through the coming winter without any coronavirus restrictions even with an expected rise in infections, Health Minister Magnus Heunicke said on Friday.

WEKU

There's no bad time to get a new COVID booster if you're eligible, CDC director says

People can get the Moderna booster if they're 18 or older, and the Pfizer-BioNTech version if they're 12 and up. In both cases, they must wait at least two months since their last COVID vaccine.

Axios

"Game-changer" Paxlovid turns into pandemic enigma

Paxlovid goes from COVID game-changer to pandemic enigma

Axios

CDC recommends updated COVID-19 boosters

The CDC recommends the new Pfizer-BioNTech booster for individuals 12 years and the Moderna vaccine for individuals 18 and up.

Los Angeles Times

CDC advisers endorse booster shots that target omicron for Americans 12 and up

The United States should replace most of its COVID-19 booster shots with updated versions that target the dominant omicron strains, an influential group of vaccine experts that advises the Centers for Disease Control and Prevention said Thursday.

1 … 34 35 36 37

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.